Related Experiment Video
Updated: Jul 6, 2026

09:04
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
Published on: May 11, 2020
Differences in vaccinations in European Union
Susanna Esposito1, Nicola Principi
1Institute of Pediatrics, University of Milan, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan, Italy. Susanna.Esposito@unimi.it
Human Vaccines
|April 10, 2008
Summary
European Union vaccination systems face challenges due to differing national approaches and public perception. A unified program could improve vaccination coverage and public health outcomes across member states.
Area of Science:
- Public Health
- Immunization Policy
Background:
- European Union Member States exhibit diverse national health services, vaccination systems, recommendations, and schedules.
- Heterogeneity in vaccination systems and varying public/healthcare worker perceptions act as barriers to widespread immunization.
- Inconsistent vaccination coverage fails to meet evolving medical needs across the EU.
Purpose of the Study:
- To identify key barriers hindering vaccination coverage in the European Union.
- To propose a unified program to enhance immunization rates and address existing limitations.
Main Methods:
- Analysis of existing vaccination systems and coverage data across EU Member States.
- Identification of critical limitations including coverage evaluation, appointment reminders, and adverse event monitoring.
Main Results:
- Significant limitations exist in evaluating vaccination coverage and monitoring adverse events.
- Lack of active patient reminder systems contributes to missed vaccination appointments.
- Heterogeneity in national vaccination strategies impedes uniform progress.
Conclusions:
- A common European vaccination program is essential to overcome existing barriers.
- Active health authority initiatives demonstrating the importance of vaccination can increase parental confidence and uptake.
- Standardized approaches are crucial for improving public health through immunization across the EU.
More Related Videos
Related Concept Videos
Vaccinations
Overview
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cross-reactivity
Overview
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

